Sunshine Biopharma Inc. (SBFM) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Sunshine Biopharma Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Sunshine Biopharma Inc.'s filing signal
continuing negative.
earningsVibe SuperAnalyst™ Verdict:
CONTINUING NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Continuing Negative
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Sunshine Biopharma Inc. actually do?
Answer:
Sunshine Biopharma Inc. operates as a pharmaceutical company focused on life-saving medicines in oncology and antivirals, with a dual strategy of commercializing generic prescription drugs in Canada and developing proprietary drug candidates. Through its wholly-owned subsidiary Nora Pharma, the company markets 71 generic prescription drugs in Canada and has 22 additional drugs in its pipeline. Its proprietary drug development includes K1.1 mRNA for liver cancer and SBFM-PL4, a protease inhibitor targeting SARS Coronavirus infections. Sunshine Biopharma Canada Inc. develops and sells OTC supplements, primarily through the Amazon marketplace in Canada. The company's commercial operations are centered on securing rights to pharmaceutical products for sale, with a strategic focus on expanding its presence in the Canadian generic drug market.
Question:
What are Sunshine Biopharma Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by the sale of generic prescription drugs in Canada through its subsidiary Nora Pharma. The company also generates revenue from the sale of OTC supplements in Canada via the Amazon marketplace.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required